Compositions and methods for inhibiting expression of RRM2 genes
US-11920134-B2 · Mar 5, 2024 · US
Boylan John Frederick is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Boylan John Frederick |
| Total patents | 16 |
| First publication | Apr 7, 2016 |
| Latest publication | Mar 5, 2024 |
Publications ranked by popularity score, then publication date.
US-11920134-B2 · Mar 5, 2024 · US
US-2023158035-A1 · May 25, 2023 · US
US-11590139-B2 · Feb 28, 2023 · US
US-2021128565-A1 · May 6, 2021 · US
US-10940152-B2 · Mar 9, 2021 · US
US-2020277610-A1 · Sep 3, 2020 · US
US-2020237768-A1 · Jul 30, 2020 · US
US-10646493-B2 · May 12, 2020 · US
US-10619160-B2 · Apr 14, 2020 · US
US-2018195074-A1 · Jul 12, 2018 · US
Latest publications not already listed above.
US-9938531-B2 · Apr 10, 2018 · US
US-9737541-B2 · Aug 22, 2017 · US
US-2017137827-A1 · May 18, 2017 · US
US-2017042902-A1 · Feb 16, 2017 · US
US-9512124-B2 · Dec 6, 2016 · US
US-2016096841-A1 · Apr 7, 2016 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Signal Pharm Llc | 10 |
| Arrowhead Pharmaceuticals Inc | 6 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 16 |
| A61K31/52 | 10 |
| C07D473/32 | 10 |
| A61K31/5377 | 10 |
| C07D239/50 | 10 |